A detailed history of Meyer Handelman CO transactions in Amgen Inc stock. As of the latest transaction made, Meyer Handelman CO holds 132,173 shares of AMGN stock, worth $38 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
132,173
Previous 129,831 1.8%
Holding current value
$38 Million
Previous $40.6 Million 4.98%
% of portfolio
1.46%
Previous 1.44%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$309.38 - $337.38 $724,567 - $790,143
2,342 Added 1.8%
132,173 $42.6 Million
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $2.29 Million - $2.78 Million
8,700 Added 7.18%
129,831 $40.6 Million
Q1 2024

Apr 11, 2024

BUY
$268.87 - $324.56 $3.63 Million - $4.38 Million
13,485 Added 12.53%
121,131 $34.4 Million
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $944,811 - $1.07 Million
-3,695 Reduced 3.32%
107,646 $31 Million
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $1.07 Million - $1.33 Million
4,895 Added 4.6%
111,341 $29.9 Million
Q2 2023

Jul 21, 2023

BUY
$214.27 - $253.37 $224,983 - $266,038
1,050 Added 1.0%
106,446 $23.6 Million
Q1 2023

Apr 11, 2023

SELL
$225.79 - $275.2 $880,581 - $1.07 Million
-3,900 Reduced 3.57%
105,396 $25.5 Million
Q4 2022

Jan 25, 2023

SELL
$229.03 - $291.01 $1.95 Million - $2.47 Million
-8,500 Reduced 7.22%
109,296 $28.7 Million
Q3 2022

Oct 04, 2022

SELL
$224.46 - $253.15 $179,568 - $202,520
-800 Reduced 0.67%
117,796 $26.6 Million
Q4 2021

Jan 25, 2022

BUY
$198.88 - $227.6 $994,400 - $1.14 Million
5,000 Added 4.4%
118,596 $26.7 Million
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $127,362 - $149,220
-600 Reduced 0.53%
113,596 $24.2 Million
Q2 2021

Aug 18, 2021

SELL
$233.58 - $259.14 $420,444 - $466,452
-1,800 Reduced 1.55%
114,196 $27.8 Million
Q1 2021

May 03, 2021

BUY
$221.91 - $258.6 $621,348 - $724,080
2,800 Added 2.47%
115,996 $28.9 Million
Q4 2020

Feb 03, 2021

BUY
$216.38 - $257.67 $459,807 - $547,548
2,125 Added 1.91%
113,196 $26 Million
Q3 2020

Oct 28, 2020

SELL
$234.65 - $260.95 $657,020 - $730,660
-2,800 Reduced 2.46%
111,071 $28.2 Million
Q2 2020

Jul 16, 2020

SELL
$197.81 - $242.74 $909,926 - $1.12 Million
-4,600 Reduced 3.88%
113,871 $26.9 Million
Q1 2020

Apr 22, 2020

BUY
$182.24 - $241.7 $272,995 - $362,066
1,498 Added 1.28%
118,471 $24 Million
Q4 2019

Jan 23, 2020

SELL
$189.21 - $243.2 $170,289 - $218,880
-900 Reduced 0.76%
116,973 $28.2 Million
Q3 2019

Oct 07, 2019

BUY
$174.11 - $208.62 $130,582 - $156,465
750 Added 0.64%
117,873 $22.8 Million
Q2 2019

Jul 23, 2019

BUY
$166.7 - $195.41 $833,500 - $977,050
5,000 Added 4.46%
117,123 $21.6 Million
Q1 2019

Apr 30, 2019

BUY
$180.87 - $203.88 $506,436 - $570,864
2,800 Added 2.56%
112,123 $20.6 Million
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $294,360 - $343,612
-1,650 Reduced 1.49%
109,323 $21.3 Million
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $251,623 - $283,672
-1,358 Reduced 1.21%
110,973 $23 Million
Q2 2018

Jul 30, 2018

BUY
$166.05 - $186.51 $91,327 - $102,580
550 Added 0.49%
112,331 $20.7 Million
Q1 2018

Apr 23, 2018

BUY
$169.43 - $198.0 $8,471 - $9,900
50 Added 0.04%
111,781 $19.1 Million
Q4 2017

Feb 07, 2018

BUY
$168.79 - $188.59 $143,471 - $160,301
850 Added 0.77%
111,731 $19.4 Million
Q3 2017

Oct 25, 2017

BUY
$167.29 - $191.0 $18.5 Million - $21.2 Million
110,881
110,881 $20.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Meyer Handelman CO Portfolio

Follow Meyer Handelman CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.